Elizabeth Parrish (Matthias Arnold/picture-alliance/dpa/AP Images)
June 28, 2021 09:19 AM EDTUpdated July 2, 11:42 AM
R&D
Discovery

Con­tro­ver­sial an­ti-ag­ing sci­en­tist — backed by Har­vard's George Church — makes a fresh round of claims on life ex­ten­sion in new mouse study

John Carroll

Editor & Founder

Jason Mast

Editor

Just weeks ago con­tro­ver­sial an­ti-ag­ing re­searcher Eliz­a­beth Par­rish at­tract­ed con­sid­er­able at­ten­tion for a tiny hu­man gene ther­a­py study she claimed was …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times